Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota

NCT02968511 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.

NCT NCT02968511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02968511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota
Lead sponsor
Milton S. Hershey Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
September 15, 2016
Completion date
November 14, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c.difficile colitis